Once the patent is granted, it is expected to last through 2031, according to the report. The company plans to file for CE marking later this year. Clinical trials for FDA approval will be initiated in 2016.
More articles on gastroenterology:
7 things for gastroenterologists to know for today – April 24, 2015
4 GI physicians making headlines – April 24, 2015
Expanding services: The best ancillary lines for GI practices to consider in 2015
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
